2025 H2 -tulosraportti
159 päivää sitten
‧38 min
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 | ||
2023 H2 -tulosraportti 28.2.2024 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·20 min sittenThere's a good chance that the gap will be closed before any potential further rise, so it's still not too late to sell. Tybring
·54 min sittenI wonder what those of you with a bit deeper technical analysis skills think. Looking back at the last six months/year so far, I read that those rounds of Qube-shorting and DNB's price target pulled the share price down so much that now that we've gotten back above 5, I no longer see where the support levels are… Is there any support before it gets all the way down to 4kr? Or is it quite undefined where the support levels are?
Technical analysis skills are irrelevant for TRMED's development. It fits in a completely different situation...........
·57 min sittenA lot is written and said here. Many refer to historical data. Fair enough. The day the first delivery is announced will be a good day. Other news may also come. Artic's updated price target was 5 kr. And that was a long time ago... much has happened since then. But people can do as they please. Have a nice day 😊
I think Artic had already priced in the completed startup in its price target. Now Thor must make money before the price can go further up.
·1 t sittenJust as I said before opening. I've been following this stock for so long now that I'm starting to understand its mechanisms. It often shoots up a lot, but also goes down almost as often by the same amount shortly after. "What goes up must come down" I believe in it long-term, but a lot of ups and downs before then. I don't understand all those who absolutely have to say it's "on sale" every time it drops a few percent. I feel it's a bit of reverse psychology and fear that makes them have to "tempt" others to buy in so it will rise again. Just saying. But, in Thor we trust👍 Let the speculators carry on, they will do so no matter what the forum experts here say. Innit for the long run.
Agree with much here, it's amusing with such stocks where the cope mechanism when the price falls is "good that I get to buy more" or as mentioned that it's on sale. It just becomes too silly.- ·1 t sittenThe short-term hype may have died down a lot, but one fact remains from the price increase: We are one step closer to revenue, and now we are so close to that door that we only have to wait until August is over to know when the first delivery will come. With a backlog of 800~ million, several partnership agreements in the last six months, and many good news around the market and demand, I am personally willing to sit still through red days like this. The reason is that one can never know when the next news will come. 21 000 patient doses after 3 years, seems «little» in this growing market, therefore I would have thought that a further expansion for thor medical is relevant within these years, where A2 perhaps produces ten times as much after a few years. This stock has gone from a project to one that sells the shovels for cancer medicine. I choose to hold, at least, because here I see nothing but a long-term upward surge in the coming months/years.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H2 -tulosraportti
159 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·20 min sittenThere's a good chance that the gap will be closed before any potential further rise, so it's still not too late to sell. Tybring
- ·54 min sittenI wonder what those of you with a bit deeper technical analysis skills think. Looking back at the last six months/year so far, I read that those rounds of Qube-shorting and DNB's price target pulled the share price down so much that now that we've gotten back above 5, I no longer see where the support levels are… Is there any support before it gets all the way down to 4kr? Or is it quite undefined where the support levels are?Technical analysis skills are irrelevant for TRMED's development. It fits in a completely different situation...........
- ·57 min sittenA lot is written and said here. Many refer to historical data. Fair enough. The day the first delivery is announced will be a good day. Other news may also come. Artic's updated price target was 5 kr. And that was a long time ago... much has happened since then. But people can do as they please. Have a nice day 😊I think Artic had already priced in the completed startup in its price target. Now Thor must make money before the price can go further up.
- ·1 t sittenJust as I said before opening. I've been following this stock for so long now that I'm starting to understand its mechanisms. It often shoots up a lot, but also goes down almost as often by the same amount shortly after. "What goes up must come down" I believe in it long-term, but a lot of ups and downs before then. I don't understand all those who absolutely have to say it's "on sale" every time it drops a few percent. I feel it's a bit of reverse psychology and fear that makes them have to "tempt" others to buy in so it will rise again. Just saying. But, in Thor we trust👍 Let the speculators carry on, they will do so no matter what the forum experts here say. Innit for the long run.Agree with much here, it's amusing with such stocks where the cope mechanism when the price falls is "good that I get to buy more" or as mentioned that it's on sale. It just becomes too silly.
- ·1 t sittenThe short-term hype may have died down a lot, but one fact remains from the price increase: We are one step closer to revenue, and now we are so close to that door that we only have to wait until August is over to know when the first delivery will come. With a backlog of 800~ million, several partnership agreements in the last six months, and many good news around the market and demand, I am personally willing to sit still through red days like this. The reason is that one can never know when the next news will come. 21 000 patient doses after 3 years, seems «little» in this growing market, therefore I would have thought that a further expansion for thor medical is relevant within these years, where A2 perhaps produces ten times as much after a few years. This stock has gone from a project to one that sells the shovels for cancer medicine. I choose to hold, at least, because here I see nothing but a long-term upward surge in the coming months/years.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 | ||
2023 H2 -tulosraportti 28.2.2024 |
2025 H2 -tulosraportti
159 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 | ||
2024 H1 -tulosraportti 30.8.2024 | ||
2023 H2 -tulosraportti 28.2.2024 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·20 min sittenThere's a good chance that the gap will be closed before any potential further rise, so it's still not too late to sell. Tybring
- ·54 min sittenI wonder what those of you with a bit deeper technical analysis skills think. Looking back at the last six months/year so far, I read that those rounds of Qube-shorting and DNB's price target pulled the share price down so much that now that we've gotten back above 5, I no longer see where the support levels are… Is there any support before it gets all the way down to 4kr? Or is it quite undefined where the support levels are?Technical analysis skills are irrelevant for TRMED's development. It fits in a completely different situation...........
- ·57 min sittenA lot is written and said here. Many refer to historical data. Fair enough. The day the first delivery is announced will be a good day. Other news may also come. Artic's updated price target was 5 kr. And that was a long time ago... much has happened since then. But people can do as they please. Have a nice day 😊I think Artic had already priced in the completed startup in its price target. Now Thor must make money before the price can go further up.
- ·1 t sittenJust as I said before opening. I've been following this stock for so long now that I'm starting to understand its mechanisms. It often shoots up a lot, but also goes down almost as often by the same amount shortly after. "What goes up must come down" I believe in it long-term, but a lot of ups and downs before then. I don't understand all those who absolutely have to say it's "on sale" every time it drops a few percent. I feel it's a bit of reverse psychology and fear that makes them have to "tempt" others to buy in so it will rise again. Just saying. But, in Thor we trust👍 Let the speculators carry on, they will do so no matter what the forum experts here say. Innit for the long run.Agree with much here, it's amusing with such stocks where the cope mechanism when the price falls is "good that I get to buy more" or as mentioned that it's on sale. It just becomes too silly.
- ·1 t sittenThe short-term hype may have died down a lot, but one fact remains from the price increase: We are one step closer to revenue, and now we are so close to that door that we only have to wait until August is over to know when the first delivery will come. With a backlog of 800~ million, several partnership agreements in the last six months, and many good news around the market and demand, I am personally willing to sit still through red days like this. The reason is that one can never know when the next news will come. 21 000 patient doses after 3 years, seems «little» in this growing market, therefore I would have thought that a further expansion for thor medical is relevant within these years, where A2 perhaps produces ten times as much after a few years. This stock has gone from a project to one that sells the shovels for cancer medicine. I choose to hold, at least, because here I see nothing but a long-term upward surge in the coming months/years.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt